Insulin pump maker Insulin announced partnerships yesterday with two of the leading continuous glucose monitor companies, Abbott and Dexcom. Both involve the Insulet’s Omnipod Horizon Automated Insulin Delivery System which uses a tubeless, wearable “Pod” to deliver insulin for 72 hours at a time.
Abbott and Insulet have partnered to offer a new integrated digital health platform that will...
One of the biggest digital health success stories of the two decades is in the diabetes space, especially the continuous glucose monitor (or CGM). The first CGM was approved by the FDA in 1999, but in the last decade we've seen CGMs become smaller, longer lasting and more comfortable, and we've seen huge strides in datasharing as CGM-phone connectivity went from novelty to commodity.
Dexcom has...
MobiHealthNews’ parent company HIMSS and Forrester Research announced today a new research partnership that will survey health system leadership on digital health adoption and measure its impact on patient experience and physician burnout. These findings will be presented at March’s HIMSS Global Health Conference & Exhibition in Orlando.
“Uncovering emerging strategies for quantifying...
Dexcom continuous glucose monitor users and their caregivers found themselves in the dark this weekend when a key monitoring feature ceased to function with little to no warning.
The feature, called Dexcom Follow, transmits an alert when a CGM user’s blood sugar reaches a dangerous level and is often used by parents monitoring their children’s condition. When unexpected issues brought down the...
This morning the Dexcom G6 Pro Continuous Glucose Monitoring System got the greenlight from the FDA. The latest technology can gather real-time glucose data over a period of 10 days and has the ability to be switched to blinded mode or unblinded mode.
In blinded mode, patients don’t see their data automatically; instead, the clinician will get the data and then be able to discuss it with the...
In Dexcom’s latest earnings report, executives reported not only growing revenues and sales volume for the company, but a sense that the whole category of CGMs has arrived and is transforming diabetes care for the better, noting trends observed at the recent annual meeting of the American Diabetes Association.
“We have been on record for years telling that the future is ‘CGM First’ and we believe...
Roughly a year after its launch, Walgreens Boots Alliance announced that its Find Care platform — a mobile and web tool guiding consumers toward curated health services — has added eight new partners including Propeller Health, Dexcom and a handful of regional health systems.
The two digital companies’ connected inhaler sensors and CGM devices add new chronic care management options to the retail...
Implantable CGM company Senseonics has received approval from the FDA for the non-adjunctive indication for its Eversense device.
Senseonics is only the third company to secure this indication, which allows a CGM to be used for insulin dosing in lieu of a fingerstick glucometer, though patients will still need to use fingersticks twice a day for calibration.
The company plans to go live with the...
For folks managing their diabetes with Dexcom, Siri can now answer one more question: What is my glucose level? This morning Dexcom announced a slew of new companion app features for the Dexcom G6 continuous glucose monitoring system, including the ability for Siri to read a user’s glucose level out loud and display graphs directly on the lock screen.
The app, which was released in 2018, will...
Dexcom held its Q4 2018 earnings call last week, reporting an overall very strong year, but also announcing outsourcing plans that will likely lead to layoffs in the US.
The company broke $1 billion in annual revenue in 2018, CEO Kevin Sayer said on the call, while increasing adoption, especially in Medicare and international markets, both of which are new to the company. And the company has set...
